Pharma Business review is using cookies

ContinueLearn More
Close

News

August 16, 2018

Novocure, US Oncology collaborate on advanced pancreatic cancer trial

Novocure and US Oncology Research are collaborating on PANOVA-3, a phase 3 pivotal trial testing the efficacy of Tumor Treating Fields combined with nab-paclitaxel and gemcitabine in patients with unresectable locally advanced pancreatic cancer.

Novocure, US Oncology collaborate on advanced pancreatic cancer trial